Robuta

https://pubmed.ncbi.nlm.nih.gov/18552703/
While guanfacine appears to be an alternative to psychostimulants among children with developmental disabilities, clinicians need to remain vigilant to the...
intellectual disabilitiesguanfacinechildrenautism
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=87e1ad56-a7b9-431d-a5d2-d52fb64735c7
guanfacinetabletsuspmgrx
https://www.medicines.org.uk/emc/product/101840/smpc
Guanfacine 2 mg prolonged-release tablets - Summary of Product Characteristics (SmPC) by Neuraxpharm UK Ltd
prolonged releaseproduct characteristicsguanfacinemgtablets
https://www.poison.org/articles/clonidine-and-guanfacine-uses-side-effects-safety-194
Clonidine and guanfacine began as treatments for hypertension but have been found useful in managing attention-deficit/hyperactivity disorder (ADHD). Both...
side effectspoison controlclonidineguanfacineuses
https://www.goodrx.com/compare/guanfacine-vs-intuniv
Compare Guanfacine and Intuniv side effects, costs and risks for treating Hypertension and ADHD.
guanfacinevsintunivhypertensionadhd
https://pubmed.ncbi.nlm.nih.gov/20806988/
extended releaseeffectsguanfacineoppositionalsymptoms
https://www.medicines.org.uk/emc/product/101840/pil
Guanfacine 2 mg prolonged-release tablets - Patient Information Leaflet (PIL) by Neuraxpharm UK Ltd
patient information leafletprolonged releaseguanfacinemgtablets
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=35d3c996-1755-c017-e063-6294a90abc1f
extended releasedailymedguanfacinetablet
https://www.medicines.org.uk/emc/product/101850/pil
Guanfacine 7 mg prolonged-release tablets - Patient Information Leaflet (PIL) by Neuraxpharm UK Ltd
patient information leafletprolonged releaseguanfacinemgtablets
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=286214e2-a65b-f43b-e063-6394a90a33be&audience=professional
extended releasedailymedguanfacineertablet